U. of Colo. Says Amgen Withholding Arthritis Med Royalties
Amgen Inc. is withholding more than $1 million in royalty payments owed to the University of Colorado for patent licenses for the arthritis drug Kineret, the university claimed in a lawsuit...To view the full article, register now.
Already a subscriber? Click here to view full article